Aadi Bioscience, Inc

Aadi Bioscience, Inc company information, Employees & Contact Information

Aadi Bioscience Inc. (Aadi) is a biopharmaceutical company focused on precision therapies for genetically-defined cancers. We strive to unleash the potential of mTOR inhibition by employing precision medicine & nanoparticle technology to bring transformational therapies to cancer patients with mTOR pathway driver alterations. Our lead product has been FDA-approved for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumors (PEComa). In March 2025, we became a wholly-owned subsidiary of KAKEN Pharmaceutical Co., Ltd., an R&D driven pharmaceutical company in Japan. A science-first mindset and patient-centric approach is always in our genes. Together with KAKEN, we continue to dedicate to developing products for cancers with mTOR pathway driver alterations. For more information, please visit: https://aadibio.com/ and https://www.kaken.co.jp/english/.

Company Details

Employees
50
Founded
-
Address
2 Headquarters Plz, East Tower
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Morristown, New Jersey
Looking for a particular Aadi Bioscience, Inc employee's phone or email?

Aadi Bioscience, Inc Questions

News

Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing - Yahoo Finance

Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing Yahoo Finance

Aadi Bioscience Provides PRECISION1 Trial and Corporate Updates - PR Newswire

Aadi Bioscience Provides PRECISION1 Trial and Corporate Updates PR Newswire

Aadi Bioscience Filed Definitive Proxy Statement and Schedules Special Meeting of Stockholders for February 28, 2025 - PR Newswire

Aadi Bioscience Filed Definitive Proxy Statement and Schedules Special Meeting of Stockholders for February 28, 2025 PR Newswire

AADI - Aadi Bioscience Inc Latest Stock News & Market Updates - Stock Titan

AADI - Aadi Bioscience Inc Latest Stock News & Market Updates Stock Titan

Aadi Bioscience Announces Publication of its Phase 2 Registrational (AMPECT) Trial of nab-Sirolimus in Patients with Malignant Perivascular Epithelioid Cell Tumors in the Journal of Clinical Oncology - Yahoo Finance

Aadi Bioscience Announces Publication of its Phase 2 Registrational (AMPECT) Trial of nab-Sirolimus in Patients with Malignant Perivascular Epithelioid Cell Tumors in the Journal of Clinical Oncology Yahoo Finance

Aadi Bioscience Appoints David Dornan, PhD, as Chief Scientific Officer - PR Newswire

Aadi Bioscience Appoints David Dornan, PhD, as Chief Scientific Officer PR Newswire

Aadi Bioscience Appoints Loretta Itri as Chief Medical Officer - Yahoo Finance

Aadi Bioscience Appoints Loretta Itri as Chief Medical Officer Yahoo Finance

Aadi Bioscience Announces Financial Results for the Second Quarter 2024 and Provides Corporate Update - PR Newswire

Aadi Bioscience Announces Financial Results for the Second Quarter 2024 and Provides Corporate Update PR Newswire

Aadi Bioscience Announces $72.5 Million Private Placement Equity Financing - PR Newswire

Aadi Bioscience Announces $72.5 Million Private Placement Equity Financing PR Newswire

Mirati Therapeutics and Aadi Bioscience Partner to Evaluate the Combination of Adagrasib with Nab-sirolimus in Patients with Advanced Non-Small Cell Lung Cancer and Other Solid Tumors with a KRAS[G12C] Mutation - PR Newswire

Mirati Therapeutics and Aadi Bioscience Partner to Evaluate the Combination of Adagrasib with Nab-sirolimus in Patients with Advanced Non-Small Cell Lung Cancer and Other Solid Tumors with a KRAS[G12C] Mutation PR Newswire

Top Aadi Bioscience, Inc Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant